Medivation Inc (MDVN)

MDVN (NASDAQ:Drugs) EQUITY
$113.56
pos +1.50
+1.34%
Today's Range: 110.56 - 115.42 | MDVN Avg Daily Volume: 927,000
Last Update: 07/06/15 - 4:00 PM EDT
Volume: 1,692,684
YTD Performance: 12.50%
Open: $112.53
Previous Close: $112.06
52 Week Range: $69.11 - $141.58
Oustanding Shares: 78,694,031
Market Cap: 8,818,453,114
6-Month Chart
TheStreet Ratings Grade for MDVN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 11 11 11
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.57 1.57 1.57 1.57
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 30.04
Price Earnings Comparisons:
MDVN Sector Avg. S&P 500
30.04 33.20 26.10
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-13.94% 43.32% 136.89%
GROWTH 12 Mo 3 Yr CAGR
Revenue 160.30 10.77 1.26
Net Income 0.00 -8.12 0.00
EPS 0.00 -7.41 0.00
Earnings for MDVN:
EBITDA 0.28B
Revenue 0.71B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $0.34 $0.87 $3.03 $4.22
Number of Analysts 6 6 7 7
High Estimate $0.58 $1.24 $4.12 $4.57
Low Estimate $0.18 $0.53 $1.91 $3.68
Prior Year $0.60 $0.96 $3.42 $3.03
Growth Rate (Year over Year) -43.06% -9.03% -11.40% 39.13%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jun 5, 2015 | 1:23 PM EDT

With hacking and cyber security making headlines, Jim Cramer recommended a few cyber security stocks for investors, including Palo Alto Networks (PANW), Fortinet (FTNT), FireEye (FEYE), and Cyberark Software (CYBR).

bearishMedivation downgraded at Credit Suisse

Apr 20, 2015 | 7:23 AM EDT

MDVN was downgraded from Outperform to Neutral, Credit Suisse said. $115 price target. New analyst believes the company is facing growth headwinds. 

By

Robert Moreno

 | Feb 19, 2015 | 2:10 PM EST

Chart setups in Celgene, Medivation and AMAG Pharmaceuticals.

By

James "Rev Shark" DePorre

 | Nov 7, 2014 | 4:46 PM EST

It's the only way to deal with this market.

bearishMedivation downgraded at Goldman

Sep 24, 2014 | 6:45 AM EDT

MDVN was downgraded from Buy to Neutral, Goldman Sachs said. Valuation call, based on a $110 price target.

bullishMedivation upgraded at Canaccord

Sep 18, 2014 | 7:20 AM EDT

MDVN was upgraded to Buy, Canaccord Genuity said. $132 price target. Company is gaining market share in the pre-chemotherapy market. 

By

Dick Arms

 | Sep 16, 2014 | 7:15 AM EDT

Consider going short if you aren't already.

bullishMedivation upgraded at Bernstein

Sep 9, 2014 | 8:12 AM EDT

MDVN was upgraded from Market Perform to Outperform, Bernstein said. $118 price target. Prevail should drive growth. 

bearishMedivation price target, EPS cut at UBS

Mar 3, 2014 | 7:49 AM EST

MDVN lowered its numbers, UBS said. Driven by disappointing Xtandi guidance. $85 price target and Buy rating, 

bearishMedivation downgraded at Needham

Feb 3, 2014 | 7:36 AM EST

MDVN was downgraded from Buy to Hold, Needham said. Valuation call. 

 

Telecom equipment makers are more than likely staring another weak demand quarter in the f...
one would think with a 7%+ drop in crude oil that airlines might catch a bid. That is not...
My futures chart includes the overnight data. My SPX chart does not. Even though both of...
So far this one is still holding above the key support decisions on the daily chart. I am ...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.